Results for tag: "Bexsero"

Bexsero is a vaccine developed by Novartis Vaccines and Diagnostics, Inc. It is used to protect against meningococcal disease, a potentially life-threatening infection caused by the bacterium Neisseria meningitidis. Bexsero is approved for use in the United States, Europe, Canada, Australia, and other countries. It is administered as a two-dose series, with the second dose given at least one month after the first. The Bexsero market is a rapidly growing segment of the global vaccine industry. It is driven by the increasing prevalence of meningococcal disease, as well as the growing awareness of the need for vaccination. The market is expected to continue to grow in the coming years, as more countries adopt the vaccine and as new formulations are developed. Some of the major companies in the Bexsero market include Novartis Vaccines and Diagnostics, Inc., GlaxoSmithKline, Pfizer, Merck, Sanofi Pasteur, and AstraZeneca. Show Less Read more